The aim of this prospective clinical study was to compare the results of B-glucose estimations performed simultaneously on glucometer Advance (with Micro-draw strips) and Optium (G3 strips) by lay healthy volunteers under non-standardized conditions of everyday life, to assess the difficulties dealing with lay-handling of these systems and to demonstrate the possibilities of the software Glucobalance (Hypoguard) and PC-Link (Medisense/Abbott) for the analysis of selfmonitoring. In the course of 5 days, a total of 721 pairs of measurements were carried out on 10 pairs of glucometer Advance and Optium by 10 healthy volunteers aged 16-40 years. The data transfer of all values into computer from glucometer Advance using the Glucobalance software and from glucometer Optium using the PC-Link was carried out to determine the results. The correlation of B-glucose measured on the glucometer Advance and Optium was strong (r = 0.73). Glucometer Advance brings values about 0.21 ± 0.06 mmol/l lower than glucometer Optium. The average difference found within each pairs of glucometers Advance-Optium varied. Nevertheless, these differences are acceptable for routine selfmonitoring. The handling of glucometer Advance is not difficult for lay persons. The Glucobalance software simplifies the result evaluation by each tested person. Even though there are some advantages in comparison with the PC-Link, it should be further developed.
95The OBJECTIVE of this presentation has been to summarize some preliminary results concerning malignancies of patients with regard to their medical history of allergic manifestations (ALL).The SAMPLE: Patients followed at St. Mary's Hospital (SMH). The study consisted of adult patients (15 years and over) admitted at SMH with all kinds of diagnoses. During the 32 year period , a total of 470,462 patients have been admitted at SMH, which represents a yearly admittance average of 14,702 patients. Our sample concerned the subtotal of 12,206 patients with malignant tumors, admitted at SMH during the 32 year period (yearly average of 381 patients), with or without a history of ALL. Patients followed at SMH in several out-patient clinics as well as those treated at home under SMH supervision, or in other SMH-connected facilities have been excluded from this survey. Repeated admissions of the same patient with malignant tumor have been considered as separate cases. From the subtotal of 12,206 admitted malignancies, 366 have been identified with both tumors and ALL, which represents 3.0% during the 32 year period . The remaining 11,840 patients with tumors but no recorded ALL amounted thus to 97.0% of the hospital admitted malignancies. The latest decimal WHO-classification of diseases has been used for diagnosing of both tumors and ALL. 4 For the exhaustive summarization see Table 1.From our target population of 366 patients with both tumors and ALL, we have been able to study in more details the earlier period than the more recent one (1990)(1991)(1992)(1993)(1994)(1995)(1996). The 366 patients represent an incidence of 11.4 cases per year. Calculations of chi-square as well as the expected and observed frequencies have been performed. The shortcomings and biases of our approach have been taken into consideration. 5 The respective chi-square testing is equivalent with the comparison of the relative frequencies of the occurrence of ALL in tumorous and non-tumorous groups.Some RESULTS from the first period : there were 187 patients with both tumors and ALL (51.1% from the total of 366 patients . The sex distribution among them was quite uniform: 49.2% of men and 50.8% of women. The average age amounted to 66.4 years; it was higher among men (68.3 years) than among women (64.5 years). The distribution of age groups formed a typical bell-shaped curve, with a peak in the 60-69 age group. Smoking was not a determinant; this information was available among 72.7% of patients. Neither was the type of occupation a discriminating factor. Patients with a history of ALL concerned the following categories of tumors (in decreasing order): malignancies of the digestive system (26%), urogenital tumors (16%), respiratory tumors (13%), gynecologic tumors, breast cancers, malignant hemopathies (about 10% in each category) and about 15% of other malignancies. 3 Some COMMENTS for the total 32 year period :The observed value of 366 patients admitted at SMH with a confirmed malignancy, having had a recorded history of ALL, is relatively lo...
The distribution of nuclei in macroconidia was investigated in 20 strains of the dermatophyte Microsporum gypseum by fluorescence microscopy. The macroconidia were characterized by the right-left and the central-marginal symmetry indices. In 18 strains the significant majority of the nuclei were situated in the basal part of the macroconidium, the remaining 2 strains showed a more or less uniform distribution of nuclei. All strains had higher numbers of nuclei in the central part of the macroconidium as compared with the periphery.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.